Xeltis
Netherlands - EindhovenBiotechnology
Focus: Xeltis is a Netherlands-based tissue engineering biotech founded in 2016, developing bioabsorbable medical devices and regenerative solutions for cardiovascular, renal, and women's health indications. The company is publicly traded and recently raised €20.5M to advance its pipeline of artificial vessels and valves.
Profile data last refreshed 16h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
5-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at Xeltis?
AI assessmentBest fit for tissue-engineering specialists and manufacturing engineers willing to bet on early-stage device innovation; not ideal for those seeking established pharma infrastructure or immediate commercial scale.
Why Work Here
- Pioneering tissue engineering platform with clinical-stage devices across high-unmet-need areas (congenital heart disease, end-stage renal disease, peripheral arterial disease).
Data completeness
6/9 — Partial
Company HealthWatch
Pipeline
Early-stage
12 total
LOE Risk
1 imminent
BALCOLTRA
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$2M Part DStable
Peak4.6yr
Only novel NDA in commercial portfolio and primary revenue driver; progestin-only formulation with 5+ years of patent exclusivity remaining.
Help build intelligence for Xeltis
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.